Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Kraig Biocraft Laboratories FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kraig Biocraft Laboratories's Free Cash Flow for the three months ended in Dec. 2023 was $-0.33 Mil. Kraig Biocraft Laboratories's Revenue for the three months ended in Dec. 2023 was $0.00 Mil. Therefore, Kraig Biocraft Laboratories's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Kraig Biocraft Laboratories's current FCF Yield % is -1.31%.

The historical rank and industry rank for Kraig Biocraft Laboratories's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of Kraig Biocraft Laboratories was -61.19%. The lowest was -3168.75%. And the median was -784.54%.

KBLB's FCF Margin % is not ranked ^*
in the Chemicals industry.
Industry Median: 0.97
* Ranked among companies with meaningful FCF Margin % only.

Kraig Biocraft Laboratories FCF Margin % Historical Data

The historical data trend for Kraig Biocraft Laboratories's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kraig Biocraft Laboratories FCF Margin % Chart

Kraig Biocraft Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

Kraig Biocraft Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Kraig Biocraft Laboratories's FCF Margin %

For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kraig Biocraft Laboratories's FCF Margin % Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kraig Biocraft Laboratories's FCF Margin % falls into.

Kraig Biocraft Laboratories FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kraig Biocraft Laboratories's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1.25	/	0
	=	%

Kraig Biocraft Laboratories's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-0.328	/	0
	=	%

Kraig Biocraft Laboratories FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kraig Biocraft Laboratories's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kraig Biocraft Laboratories (Kraig Biocraft Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Kraig Biocraft Laboratories Inc (OTCPK:KBLB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104

Website

https://www.kraiglabs.com

Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fibers using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; and Dragon Silk, which combines the elasticity of Monster Silk with additional high strength elements of native spider silk; Spydasilk; and Spydra. It generates the majority of its revenues from its business across the United States.

Executives

Jonathan Richard Rice	officer: COO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48104
Kimberly Kraig Thompson	director, 10 percent owner, officer: CEO, CFO	2723 S STATE STREET, SUITE 150, ANN ARBOR MI 48401